Dissection of PIK3CA Aberration for Cervical Adenocarcinoma Outcomes

SIMPLE SUMMARY: There is limited information about genomic markers, especially for cervical adenocarcinoma treatment decisions. In this prospective study, it was found that nonsynonymous PIK3CA mutation detected in the patient’s circulating DNA collected before treatment or during follow-up was sign...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancers (Basel)
Egile Nagusiak: Chung, Tony K. H., Doran, Graeme, Cheung, Tak-Hong, Yim, So-Fan, Yu, Mei-Yung, Worley, Michael J., Elias, Kevin M., Thorner, Aaron R., Pedamallu, Chandra Sekhar, Ojesina, Akinyemi I., Lau, Kei-Man, Ducar, Matthew D., Wong, Raymond R. Y., Wang, Vivian W., Nag, Anwesha, Wollison, Bruce M., Dalgarno, Audrey, Lee, Jacqueline H. S., Yeung, Suet-Ying, Wong, Lo, Horowitz, Neil S., Davis, Michelle R., Leung, Shuk-On A., Mu, Yi, Mok, Samuel C., Chan, Paul K. S., Lawrence, Michael S., Crum, Christopher P., Chiu, Rossa W. K., Berkowitz, Ross S., Wong, Yick-Fu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8269188/
https://ncbi.nlm.nih.gov/pubmed/34203201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13133218
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak